The remodeling of the facility is scheduled to begin in mid-2021, and the first tubing should be produced under clean room conditions starting at the end of 2022. The manufacturer has already run out of capacities for some of its product groups, including complex thermoplastic tubing. COO Martin Schenkel said: “We have been feeling this effect even more strongly as a result of the increased demand for components used in infusion and feeding applications that we have seen in recent months.” To ensure long-term growth in tubing extrusion, the company based in the northeastern Bavarian city of Helmbrechts will invest several million euros in the Feuchtwangen plant in future years.
Raumedic currently employs about 90 people at its location in Feuchtwangen. Additional industrial jobs are expected to be created as part of the expansion. At its base in northern Bavaria, the medical technology manufacturer produces annually about 380 million meters of tubing made from a range of medical grade plastics, some of which are created in the company’s own compounding facilities. The solutions are used by well-known global players in the medical device and pharmaceutical industry.